VALIDATED EXECUTIVE ENGAGEMENTS
POOL + OUTREACH
INTERACTIONS
PARTICIPANTS
VALIDATIONS
* Login to view program details and full enterprise executive list.
DATE
JULY 2020
TABLES
80
PAGES
157
EDITION
9
PRICE
USD $4950
Focus On Immune Checkpoint Inhibitors, One of the Largest Segments in the Immuno-Oncology Market.
Will this Market be a Huge Opportunity by 2025?
INSIDER ACCESS PRIVILEGES
KEY DIFFERENTIATORS
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Global Competitor Market Shares |
| Immuno-Oncology Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| Immuno-Oncology Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027 |
| Immuno-Oncology Market Share Shift across Key Geographies Worldwide: 2020 VS 2027 |
| Immune Checkpoint Inhibitors (Therapy Type) World Market by Region/Country in US$ Million: 2020 to 2027 |
| Immune Checkpoint Inhibitors (Therapy Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027 |
| Immune System Modulators (Therapy Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027 |
| Immune System Modulators (Therapy Type) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027 |
| Cancer Vaccines (Therapy Type) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027 |
| Cancer Vaccines (Therapy Type) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027 |
| Oncolytic Virus (Therapy Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027 |
| Oncolytic Virus (Therapy Type) Market Share Breakdown by Region/Country: 2020 VS 2027 |
| Other Therapy Types (Therapy Type) World Market by Region/Country in US$ Million: 2020 to 2027 |
| Other Therapy Types (Therapy Type) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027 |
| Melanoma (Cancer Type) World Market Estimates and Forecasts in US$ Million by Region/Country: 2020 to 2027 |
| Melanoma (Cancer Type) Market Percentage Share Distribution by Region/Country: 2020 VS 2027 |
| Lung Cancer (Cancer Type) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2020 to 2027 |
| Lung Cancer (Cancer Type) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027 |
| Blood Cancer (Cancer Type) World Market by Region/Country in US$ Million: 2020 to 2027 |
| Blood Cancer (Cancer Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027 |
| Renal Cell Carcinoma (Cancer Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027 |
| Renal Cell Carcinoma (Cancer Type) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027 |
| Bladder Cancer (Cancer Type) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027 |
| Bladder Cancer (Cancer Type) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027 |
| Other Cancer Types (Cancer Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027 |
| Other Cancer Types (Cancer Type) Market Share Breakdown by Region/Country: 2020 VS 2027 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| UNITED STATES |
| Market Facts & Figures |
| US Immuno-Oncology Market Share (in %) by Company: 2019 & 2025 |
| United States Immuno-Oncology Market Estimates and Projections in US$ Million by Therapy Type: 2020 to 2027 |
| United States Immuno-Oncology Market Share Breakdown by Therapy Type: 2020 VS 2027 |
| United States Immuno-Oncology Market Estimates and Projections in US$ Million by Cancer Type: 2020 to 2027 |
| United States Immuno-Oncology Market Share Breakdown by Cancer Type: 2020 VS 2027 |
| CANADA |
| Canadian Immuno-Oncology Market Estimates and Forecasts in US$ Million by Therapy Type: 2020 to 2027 |
| Immuno-Oncology Market in Canada: Percentage Share Breakdown of Sales by Therapy Type for 2020 and 2027 |
| Canadian Immuno-Oncology Market Estimates and Forecasts in US$ Million by Cancer Type: 2020 to 2027 |
| Immuno-Oncology Market in Canada: Percentage Share Breakdown of Sales by Cancer Type for 2020 and 2027 |
| JAPAN |
| Japanese Market for Immuno-Oncology: Annual Sales Estimates and Projections in US$ Million by Therapy Type for the Period 2020-2027 |
| Japanese Immuno-Oncology Market Share Analysis by Therapy Type: 2020 VS 2027 |
| Japanese Market for Immuno-Oncology: Annual Sales Estimates and Projections in US$ Million by Cancer Type for the Period 2020-2027 |
| Japanese Immuno-Oncology Market Share Analysis by Cancer Type: 2020 VS 2027 |
| CHINA |
| Chinese Immuno-Oncology Market Growth Prospects in US$ Million by Therapy Type for the Period 2020-2027 |
| Chinese Immuno-Oncology Market by Therapy Type: Percentage Breakdown of Sales for 2020 and 2027 |
| Chinese Immuno-Oncology Market Growth Prospects in US$ Million by Cancer Type for the Period 2020-2027 |
| Chinese Immuno-Oncology Market by Cancer Type: Percentage Breakdown of Sales for 2020 and 2027 |
| EUROPE |
| Market Facts & Figures |
| European Immuno-Oncology Market: Competitor Market Share Scenario (in %) for 2019 & 2025 |
| European Immuno-Oncology Market Demand Scenario in US$ Million by Region/Country: 2018-2025 |
| European Immuno-Oncology Market Share Shift by Region/Country: 2020 VS 2027 |
| European Immuno-Oncology Market Estimates and Forecasts in US$ Million by Therapy Type: 2020-2027 |
| European Immuno-Oncology Market Share Breakdown by Therapy Type: 2020 VS 2027 |
| European Immuno-Oncology Market Estimates and Forecasts in US$ Million by Cancer Type: 2020-2027 |
| European Immuno-Oncology Market Share Breakdown by Cancer Type: 2020 VS 2027 |
| FRANCE |
| Immuno-Oncology Market in France by Therapy Type: Estimates and Projections in US$ Million for the Period 2020-2027 |
| French Immuno-Oncology Market Share Analysis by Therapy Type: 2020 VS 2027 |
| Immuno-Oncology Market in France by Cancer Type: Estimates and Projections in US$ Million for the Period 2020-2027 |
| French Immuno-Oncology Market Share Analysis by Cancer Type: 2020 VS 2027 |
| GERMANY |
| Immuno-Oncology Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Therapy Type for the Period 2020-2027 |
| German Immuno-Oncology Market Share Breakdown by Therapy Type: 2020 VS 2027 |
| Immuno-Oncology Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Cancer Type for the Period 2020-2027 |
| German Immuno-Oncology Market Share Breakdown by Cancer Type: 2020 VS 2027 |
| ITALY |
| Italian Immuno-Oncology Market Growth Prospects in US$ Million by Therapy Type for the Period 2020-2027 |
| Italian Immuno-Oncology Market by Therapy Type: Percentage Breakdown of Sales for 2020 and 2027 |
| Italian Immuno-Oncology Market Growth Prospects in US$ Million by Cancer Type for the Period 2020-2027 |
| Italian Immuno-Oncology Market by Cancer Type: Percentage Breakdown of Sales for 2020 and 2027 |
| UNITED KINGDOM |
| United Kingdom Market for Immuno-Oncology: Annual Sales Estimates and Projections in US$ Million by Therapy Type for the Period 2020-2027 |
| United Kingdom Immuno-Oncology Market Share Analysis by Therapy Type: 2020 VS 2027 |
| United Kingdom Market for Immuno-Oncology: Annual Sales Estimates and Projections in US$ Million by Cancer Type for the Period 2020-2027 |
| United Kingdom Immuno-Oncology Market Share Analysis by Cancer Type: 2020 VS 2027 |
| REST OF EUROPE |
| Rest of Europe Immuno-Oncology Market Estimates and Forecasts in US$ Million by Therapy Type: 2020-2027 |
| Rest of Europe Immuno-Oncology Market Share Breakdown by Therapy Type: 2020 VS 2027 |
| Rest of Europe Immuno-Oncology Market Estimates and Forecasts in US$ Million by Cancer Type: 2020-2027 |
| Rest of Europe Immuno-Oncology Market Share Breakdown by Cancer Type: 2020 VS 2027 |
| ASIA-PACIFIC |
| Immuno-Oncology Market in Asia-Pacific by Therapy Type: Estimates and Projections in US$ Million for the Period 2020-2027 |
| Asia-Pacific Immuno-Oncology Market Share Analysis by Therapy Type: 2020 VS 2027 |
| Immuno-Oncology Market in Asia-Pacific by Cancer Type: Estimates and Projections in US$ Million for the Period 2020-2027 |
| Asia-Pacific Immuno-Oncology Market Share Analysis by Cancer Type: 2020 VS 2027 |
| REST OF WORLD |
| Rest of World Immuno-Oncology Market Estimates and Forecasts in US$ Million by Therapy Type: 2020 to 2027 |
| Immuno-Oncology Market in Rest of World: Percentage Share Breakdown of Sales by Therapy Type for 2020 and 2027 |
| Rest of World Immuno-Oncology Market Estimates and Forecasts in US$ Million by Cancer Type: 2020 to 2027 |
| Immuno-Oncology Market in Rest of World: Percentage Share Breakdown of Sales by Cancer Type for 2020 and 2027 |
| IV. COMPETITION |
| Total Companies Profiled : 21 Click here to request a full table of contents and more details on this project. |
| V. CURATED RESEARCH |
INSIDER ACCESS TO
Registration is required to access our data stacks.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com